KIA
NXTM

Kopp Investment Advisors’s NxStage Medical Inc. NXTM Stock Holding History

Kopp Investment Advisors’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-97,465
Closed -$2.79M – 65
2018
Q4 		$2.79M Sell
97,465
-1,400
-1% -$39.8K 2.72% 17
2018
Q3 		$2.76M Sell
98,865
-5,495
-5% -$155K 2.32% 19
2018
Q2 		$2.91M Buy
104,360
+10,472
+11% +$281K 2.73% 17
2018
Q1 		$2.33M Sell
93,888
-4,780
-5% -$116K 2.37% 19
2017
Q4 		$2.39M Sell
98,668
-7,918
-7% -$209K 2.39% 15
2017
Q3 		$2.94M Sell
106,586
-2,960
-3% -$78.9K 2.7% 14
2017
Q2 		$2.75M Sell
109,546
-8,233
-7% -$204K 2.46% 14
2017
Q1 		$3.16M Sell
117,779
-5,488
-4% -$152K 3.09% 9
2016
Q4 		$3.23M Sell
123,267
-1,730
-1% -$42.8K 3.41% 7
2016
Q3 		$3.12M Sell
124,997
-37,840
-23% -$882K 3.09% 8
2016
Q2 		$3.53M Sell
162,837
-4,095
-2% -$73.1K 1.88% 11
2016
Q1 		$2.5M Sell
166,932
-2,680
-2% -$44.9K 1.36% 13
2015
Q4 		$3.72M Buy
169,612
+20,855
+14% +$389K 1.83% 13
2015
Q3 		$2.35M Buy
148,757
+31,907
+27% +$512K 1.26% 19
2015
Q2 		$1.67M Buy
116,850
+97,200
+495% +$1.65M 0.74% 30
2015
Q1 		$340K Buy
19,650
+1,025
+6% +$18.1K 0.15% 60
2014
Q4 		$334K Buy
18,625
+1,885
+11% +$30.4K 0.16% 58
2014
Q3 		$220K Sell
16,740
-750
-4% -$10.1K 0.11% 61
2014
Q2 		$251K Sell
17,490
-1,860
-10% -$24.3K 0.12% 62
2014
Q1 		$247K Buy
19,350
+8,330
+76% +$109K 0.1% 59
2013
Q4 		$110K Buy
+11,020
New +$125K 0.05% 63

Other funds holding NXTM

TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Kopp Investment Advisors's NXTM Position: Q1 2019 in Review

Kopp Investment Advisors sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 97,465 shares — an estimated $2.79M sold.

Kopp Investment Advisors first reported a position in NXTM in Q4 2013 and held it in 21 quarters. The position peaked at $3.72M in Q4 2015. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • Kopp Investment Advisors reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • Kopp Investment Advisors sold 97,465 NxStage Medical Inc. shares in Q1 2019, an estimated $2.79M.
  • Kopp Investment Advisors first reported a position in NxStage Medical Inc. in Q4 2013 and held it in 21 quarters.
  • Kopp Investment Advisors's NxStage Medical Inc. position peaked at $3.72M in Q4 2015.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Kopp Investment Advisors's 13F filing for Q1 2019, filed 15 May 2019.